About Us.
Myogem Health Company is a company located in Mollet del Vallès, Barcelona, Spain.
The company is a spin-off of Inkemia IUCT Group, focused on the research, development, innovation, and commercialization of new products for the treatment of rare diseases and diseases with high social impact.
Rare diseases have always been treated differently compared to other diseases due to the limited number of companies willing to invest in them and the little attention they receive from the media. Myogem Health Company’s mission is to offer patients affected by these diseases the possibility of achieving a better quality of life through a range of products aimed at improving their health status. Likewise, it aims to offer solutions for diseases with high social impact, targeting conditions that affect population segments in which few companies invest in seeking potential solutions.
Our mission.
Our goal is to work for all people affected by rare or high social impact diseases, highlighting diseases of neuromuscular origin such as myotonic dystrophy or Steinert’s disease.
Vision.
Our vision is to be a global leader in the development of innovative treatments for rare or high-impact diseases, helping to improve the life expectancy and quality of life of those who suffer from them. We seek to promote research and accessibility to effective therapies based on scientific evidence.
Values.
Commitment to science – We base our work on rigorous research and verifiable results.
Constant innovation – We are committed to developing new therapeutic solutions for rare diseases.
Patients at the center – We work with a human-centered approach, prioritizing the quality of life and well-being of affected individuals.
Transparency and ethics – We act with integrity in each of our research projects and developments.
Global collaboration – We believe in cooperation with the scientific and medical communities and patient associations to achieve significant advancements.
Our goal.
We hope to become leading researchers in these conditions and, together with patient associations, we would like to join millions of people around the world in their fight against these diseases.
Team.
MyoGem has a multidisciplinary team of highly qualified scientists and professionals from MyoGem and the Inkemia Group, in collaboration with renowned external experts. The project has also received support from prestigious research institutes and university centers, allowing the integration of scientific knowledge, technical expertise, and academic rigor to create an innovative and effective formula.
The Management Team.
